Rituximab treatment for refractory nephrotic syndrome in adults: a multicenter retrospective study

Rituximab treatment for refractory nephrotic syndrome in adults: a multicenter retrospective study

Background The treatment of refractory nephrotic syndrome (RNS) is full of challenges and the role of rituximab (RTX) is not well-established, thus this study aims to demonstrate the role of RTX in RNS.Methods This was a multicenter retrospective study of all adult patients receiving RTX for RNS. Pa...

Full description

Saved in:
Bibliographic Details
Main Authors: Xiaoyan Ma, Lu Fang, Lili Sheng, Xun Zhou, Shoujun Bai, Xiujuan Zang, Yakun Wang, Mengke Li, Zexin Lv, Qin Zhong, Xinyu Yang, Yishu Wang, Yan Hu, Danying Yan, Yingfeng Shi, Hui Chen, Jinqing Li, Min Tao, Shougang Zhuang, Yi Wang, Na Liu
Format: Article
Language:English
Published: Taylor & Francis Group 2023-12-01
Series:Renal Failure
Subjects:
Refractory nephrotic syndrome
rituximab
complete remission
partial remission
safety evaluation
Online Access:https://www.tandfonline.com/doi/10.1080/0886022X.2023.2237124
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.tandfonline.com/doi/10.1080/0886022X.2023.2237124

Similar Items